Products & Services

The Arcana Institute offer is based upon our experience and professionalism in providing local and international reimbursement strategies for market access procedure variants, legal counseling related to the activities of medical service sector as well as analytical services.

We assist and guide our clients in designing and implementing an appropriate European reimbursement strategy.

Our reputation for excellence has been earned by applying experience, creativity, intellect and commitment to every project we undertake.

Pricing & Reimbursement

Market Access consultancy

Advisory & Support

In Arcana Institute, we understand the importance of a successful reimbursement and market access strategy to maximize commercial success. Our team of experts will work with you through all the phases of drug development to understand the payer, physician and patient needs, which form the basis of the strategy.

Arcana Institute conducts research following global and European standards and HTA guidelines

• Global and local dossier
• Systematic review and meta analysis,
• Economic modelling,
• Budget impact analysis
• Threshold analysis

Market Access activities executed with our cooperation will contribute to strengthening the image of your business as a modern pharmaceutical company reliable and credible, acting according the newest trends in medicine, based on the EBM and HTA guidelines.

• SWOT Analysis with Optimization of Finance Conditions
• Market Access Goal & Management Optimization (MAGMO)
• Market Access Evidence Communication Strategy
• Evidence Based Marketing Communication Strategy (EB-MCS)
• Global and local reimbursement monitoring

Advisory & Support

Supports the Market Access decision-making process and strategy implementation in full coherence with the global and local reimbursing strategy of your company, including:

• determining the decision problem(s) (target population, appropriate comparators) as well as the type and scope of the analyses which should be conducted;
• reimbursement positioning with respect to competition and target groups;
• Value Based Pricing and threshold analyses;
• developing risk-sharing agreement strategy;
• support in preparing applications for public funding and determining official prices.